Schizophrenia is a mental disorder that appears with major frequency in adolescents or youth adults, although it may appear at any age.
Like many other disorders, it can manifest itself in form of delirium, personality disorder, agitation, confusion, psychosis, social withdrawal, anomalous attitudes, etc.
There are no physical or laboratory tests to diagnose it and psychiatrists are responsible of doing so. The causes are due to genetics and environmental factors, and the symptoms and signs vary according to the individuals. Cannabis (marijuana) can trigger the first episode or the process that may extend for their whole life. There are positive, negative, cognitive and environmental symptoms recognized.
Negative symptoms are associated with the loss of illusions and normal behaviours. These symptoms are difficult to recognize as part of this disorder since they are often mislead to depression or other conditions. Symptoms include:
- “Flat affect” (the person does not move the face or speaks in a discouraged and monotonous voice)
- Lack of satisfaction in daily life
- Loss of ability to initiate and maintain planned activities
- Lack of communication, even when the person is forced to interact
People suffering from schizophrenia with negative symptoms do need help with daily life activities. They can sometimes even neglect their personal hygiene. This may make them appear lazy or not wanting to overcome the situation, but those are actually symptoms of the disorder.
The earlier the process is diagnosed, the greater the chances of recovery with treatment. The most effective treatment is the combination of medications, psychological help and self-help resources. The permanent taking of medication is essential in this disorder.
In the field of neurosciences, and within the field of neuromodulation, we find deep TMS its first-line weapon and as a cutting-edge technique, which stimulates circuits, nods and neural networks unlike the superficial stimulation (limited to the cortex). Deep TMS is a complementary alternative together with conventional therapies, providing a substantial improvement of the process.
With the repetitive activation of prefrontal regions, through small pulses of electromagnetic energy similar to the pulses of the Magnetic Resonance, administered from outside the skull, and of deep circuits related to reward, with more of 6cm of energy penetration, long-term benefits can be obtained by overexciting these neurons, allowing the devastating negative symptoms of the disorder to be treated effectively.
Treatment per session lasts around 20 minutes and it is administered on an outpatient basis without requiring special preparation. It does not produce side effects, intolerances, as it often happens with medications. Nor does it interfere with daily life activities.
Accumulated experience after 11 years of contact and management with superficial TMS, ease and guarantee the best exploitation of this new scientific progress: deep TMS.
Given the good results obtained in the clinical trials, the procedure was quickly approved by the EMA complying with the current regulations.
1. Poulet E, Brunelin J, Bediou B, Bation R, Forgeard L, Dalery J, d'Amato T, Saoud M: Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia.
Biol Psychiatry 2005, 57:188-191.
2. Hoffman RE, Hawkins KA, Gueorguieva R, Boutros NN, Rachid F, Carroll K, Krystal JH: Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations.
Arch Gen Psychiatry 2003, 60:49-56.
3. Shergill SS, Murray RM, McGuire PK: Auditory hallucinations: a review of psychological treatments.
Schizophr Res 1998, 32:137-150.
4. Poulet E, Brunelin J, Kallel L, Bediou B, Dalery J, D'amato T, Saoud M: Is rTMS efficient as a maintenance treatment for auditory verbal hallucinations? A case report.
Schizophr Res 2006, 84:183-184.
5. Hoffman RE, Boutros NN, Berman RM, Roessler E, Belger A, Krystal JH, Charney DS: Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated "voices".
Biol Psychiatry 1999, 46:130-132.
6. Fitzgerald PB, Daskalakis ZJ: A review of repetitive transcranial magnetic stimulation use in the treatment of schizophrenia.
Can J Psychiatry 2008, 53:567-576.
7. Thirthalli J, Bharadwaj B, Kulkarni S, Gangadhar BN, Kharawala S, Andrade C: Successful use of maintenance rTMS for 8 months in a patient with antipsychotic-refractory auditory hallucinations.
Schizophr Res 2008, 100:351-352.
8. Rosenberg O, Shoenfeld N, Zangen A, Kotler M, Dannon PN: Deep TMS in a resistant major depressive disorder: a brief report.
Depress Anxiety 2010, 27:465-469.
9. Rosenberg O, Zangen A, Stryjer R, Kotler M, Dannon PN: Response to deep TMS in depressive patients with previous electroconvulsive treatment.
Brain Stimul 2010, 3:211-217.
10. Levkovitz Y, Harel EV, Roth Y, Braw Y, Most D, Katz LN, Sheer A, Gersner R, Zangen A: Deep TMS overprefrontal cortex: Evaluation of antidepressant and cognitive effects indepressive patients.
Brain Stimul 2009, 2:188-200.
11. Rosenberg O, Isserles M, Levkovitz Y, Kotler M, Zangen A, Dannon PN: Effectiveness of a second deep TMS in depression: a brief report.
Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:1041-1044.
12. Isserles M, Rosenberg O, Dannon P, Levkovitz Y, Kotler M, Deutsch F, Lerer B, Zangen A: Cognitive-Emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome.
J Affect Disord 2011, 128:235-242.
13. Levkovitz Y, Rabany L, Harel EV, Zangen A: Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study.
Int J Neuropsychopharmacol 2011, 14:991-996.
14. Zangen A, Roth Y, Voller B, Hallett M: Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil.
Clin Neurophysiol 2005, 116:775-779.
15. Roth Y, Zangen A, Hallett M: A coil design for transcranial magnetic stimulation of deep brain regions.
Journal Clinical Neurophisiology 2002, 19:361-370.
16. Rosenberg O, Roth Y, Kotler M, Zangen A, Dannon P: Deep transcranial magnetic stimulation for the treatment of auditory hallucinations: a preliminary open-label study.
Ann Gen Psychiatry 2011, 10:3.
17. Levkovitz Y, Roth Y, Harel EV, Braw Y, Sheer A, Zangen A: A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation.
Clin Neurophysiol 2007, 118:2730-2744.
18. Roth Y, Amir A, Levkovitz Y, Zangen A: Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils.
J Clin Neurophysiol 2007, 24:31-38.
19. Loo CK, Sainsbury K, Mitchell P, Hadzi-Pavlovic D, Sachdev PS: A sham-controlled trial of left and right temporal rTMS for the treatment of auditory hallucinations.
Psychol Med 2009, 6:1-6.
20. Slotema CW, Blom JD, de Weijer AD, Diederen KM, Goekoop R, Looijestijn J, et al.: Can low-frequency repetitive transcranial magnetic stimulation really relieve medication-resistant auditory verbal hallucinations? Negative results from a large randomized controlled trial.
Biol Psychiatry 2011, 69:450-456.
21. Tranulis C, Sepehry AA, Galinowski A, Stip E: Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation? A metaanalysis.
Can J Psychiatry 2008, 53:577-586.
22. Roth Y, Amir A, Levkovitz Y, Zangen A: Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils.
J Clin Neurophysiol 2007, 24:31-38.
23. Lennox BR, Park SB, Medley I, Morris PG, Jones PB: The functional anatomy of auditory hallucinations in schizophrenia.
Psychiatry Res 2000, 100:13-20.